Life Sciences spotlight: GenomeKey

GenomeKey blood sample in lab

Next-generation life sciences company, GenomeKey, was recently awarded $11.4m to transform sepsis diagnosis and treatment. We had a chat with CEO, Dr Michael Roberts, to hear his story… GenomeKey at a glance: Market sector: Life Sciences Location: Bristol Number of employees: 25 Amount of funding raised: Over £16m Company growth status: Commercialisation Let’s start with GenomeKey’s…

Read More

GenomeKey awarded $11.4M to transform sepsis diagnosis and treatment

GenomeKey blood sample in lab

GenomeKey has been awarded a major grant from Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) to build a functioning, automated prototype of their desktop diagnostic device. The Bristol-based company joined our incubation programme in 2020 with a vision to build an in vitro diagnostic device that would completely transform the way we diagnose and treat sepsis…

Read More

Healthtech products – from innovation to implementation

There is a vibrant healthtech* cluster in the South West region, with over 90 healthtech startups alone in Bristol. This sector has huge potential for Bristol, but it also has significant market challenges, from how to navigate the NHS to the rapidly evolving international digital regulatory landscape. In this article we share advice for healthtech…

Read More

GenomeKey case study: Saving lives through early diagnosis of sepsis

To help our aspiring entrepreneurs and future SETsquared Bristol members, we showcase member and alumni case studies demonstrating the breadth of tech at SETsquared Bristol and what it takes to achieve success. We had a chat with GenomeKey CEO, Michael Roberts… GenomeKey Facts Start date:  August 2019 Market sector: Medtech/diagnostics Location: Bristol Number of employees: 9 growing to 12 and beyond Amount…

Read More